These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 21912451)

  • 1. Intestinal inflammation and colorectal cancer: a double-edged sword?
    Rizzo A; Pallone F; Monteleone G; Fantini MC
    World J Gastroenterol; 2011 Jul; 17(26):3092-100. PubMed ID: 21912451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Inflammation in the Development of Colorectal Cancer.
    Muthusami S; Ramachandran IK; Babu KN; Krishnamoorthy S; Guruswamy A; Queimado L; Chaudhuri G; Ramachandran I
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):77-90. PubMed ID: 32901590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential avenues for immunotherapy of colitis-associated neoplasia.
    Waldner MJ; Neurath MF
    Immunotherapy; 2012 Apr; 4(4):397-405. PubMed ID: 22512634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and colorectal cancer.
    Kraus S; Arber N
    Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of MicroRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic Approach.
    Muthusami S; Ramachandran I; Krishnamoorthy S; Sambandam Y; Ramalingam S; Queimado L; Chaudhuri G; Ramachandran IK
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):67-76. PubMed ID: 32940190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease: a model of chronic inflammation-induced cancer.
    Yang GY; Taboada S; Liao J
    Methods Mol Biol; 2009; 511():193-233. PubMed ID: 19347299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation in sporadic colorectal cancer.
    Moossavi S; Bishehsari F
    Arch Iran Med; 2012 Mar; 15(3):166-70. PubMed ID: 22369306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual role of inflammation in colon carcinogenesis.
    Monteleone G; Pallone F; Stolfi C
    Int J Mol Sci; 2012; 13(9):11071-11084. PubMed ID: 23109839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.
    Motilva V; Talero E; Calvo JR; Villegas I; Alarcón-de-la-Lastra C; Sánchez-Fidalgo S
    Curr Pharm Des; 2008; 14(1):71-95. PubMed ID: 18220820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic ulcerative colitis and colorectal cancer.
    Rogler G
    Cancer Lett; 2014 Apr; 345(2):235-41. PubMed ID: 23941831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
    Azer SA
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines: from gut inflammation to colorectal cancer.
    Fantini MC; Pallone F
    Curr Drug Targets; 2008 May; 9(5):375-80. PubMed ID: 18473765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colitis-associated cancer: the role of T cells in tumor development.
    Waldner MJ; Neurath MF
    Semin Immunopathol; 2009 Jul; 31(2):249-56. PubMed ID: 19495757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
    Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
    Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory pathways in the early steps of colorectal cancer development.
    Mariani F; Sena P; Roncucci L
    World J Gastroenterol; 2014 Aug; 20(29):9716-31. PubMed ID: 25110410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.
    Deng L; Zhou JF; Sellers RS; Li JF; Nguyen AV; Wang Y; Orlofsky A; Liu Q; Hume DA; Pollard JW; Augenlicht L; Lin EY
    Am J Pathol; 2010 Feb; 176(2):952-67. PubMed ID: 20042677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines in colitis associated cancer: potential drug targets?
    Waldner MJ; Neurath MF
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):187-94. PubMed ID: 18782026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
    Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
    Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of colorectal cancer in inflammatory bowel diseases.
    Nadeem MS; Kumar V; Al-Abbasi FA; Kamal MA; Anwar F
    Semin Cancer Biol; 2020 Aug; 64():51-60. PubMed ID: 31112753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.